EMAIL THIS PAGE TO A FRIEND

PloS one

Apoptosis of Hepatocellular Carcinoma Cells Induced by Nanoencapsulated Polysaccharides Extracted from Antrodia Camphorata.


PMID 26327534

Abstract

Antrodia camphorata is a well-known medicinal mushroom in Taiwan and has been studied for decades, especially with focus on anti-cancer activity. Polysaccharides are the major bioactive compounds reported with anti-cancer activity, but the debates on how they target cells still remain. Research addressing the encapsulation of polysaccharides from A. camphorata extract (ACE) to enhance anti-cancer activity is rare. In this study, ACE polysaccharides were nano-encapsulated in chitosan-silica and silica (expressed as ACE/CS and ACE/S, respectively) to evaluate the apoptosis effect on a hepatoma cell line (Hep G2). The results showed that ACE polysaccharides, ACE/CS and ACE/S all could damage the Hep G2 cell membrane and cause cell death, especially in the ACE/CS group. In apoptosis assays, DNA fragmentation and sub-G1 phase populations were increased, and the mitochondrial membrane potential decreased significantly after treatments. ACE/CS and ACE/S could also increase reactive oxygen species (ROS) generation, induce Fas/APO-1 (apoptosis antigen 1) expression and elevate the proteolytic activities of caspase-3, caspase-8 and caspase-9 in Hep G2 cells. Unsurprisingly, ACE/CS induced a similar apoptosis mechanism at a lower dosage (ACE polysaccharides = 13.2 μg/mL) than those of ACE/S (ACE polysaccharides = 21.2 μg/mL) and ACE polysaccharides (25 μg/mL). Therefore, the encapsulation of ACE polysaccharides by chitosan-silica nanoparticles may provide a viable approach for enhancing anti-tumor efficacy in liver cancer cells.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

A8380
5α-Androstan-17β-ol-3-one, ≥97.5%
C19H30O2
45726
Acetic acid, for luminescence, BioUltra, ≥99.5% (GC)
C2H4O2
W200603
Acetic acid, natural, ≥99.5%, FG
C2H4O2
W200611
Acetic acid, ≥99.5%, FCC, FG
C2H4O2
ARK2183
Acetic acid, glacial, PharmaGrade, USP, JP, Ph Eur, Manufactured under appropriate GMP controls for pharma or biopharmaceutical production.
C2H4O2
46955
Fluorescein, for fluorescence, free acid
C20H12O5
P0838
Potassium bromide, BioXtra, ≥99.0%
BrK
449962
Potassium bromide, anhydrous, powder, 99.999% trace metals basis
BrK
451010
Potassium bromide, anhydrous, powder, 99.95% trace metals basis
BrK
449970
Potassium bromide, anhydrous, beads, −10 mesh, ≥99.9% trace metals basis
BrK
229792
Potassium bromide, 99.99% trace metals basis
BrK
60089
Potassium bromide, BioUltra, ≥99.5% (AT)
BrK
S2889
Sodium acetate, anhydrous, for molecular biology, ≥99%
C2H3NaO2
S5636
Sodium acetate, powder, BioReagent, for electrophoresis, suitable for cell culture, suitable for insect cell culture, ≥99%
C2H3NaO2
S1429
Sodium acetate, meets USP testing specifications, anhydrous
C2H3NaO2
229873
Sodium acetate, 99.995% trace metals basis
C2H3NaO2
S7545
Sodium acetate, BioXtra, ≥99.0%
C2H3NaO2
71183
Sodium acetate, anhydrous, BioUltra, for luminescence, for molecular biology, ≥99.0% (NT)
C2H3NaO2
W302406
Sodium Acetate Anhydrous, >99%, FCC, FG
C2H3NaO2
71196
Sodium acetate solution, BioUltra, for molecular biology, ~3 M in H2O
C2H3NaO2
342483
Sodium phosphate, 96%
Na3O4P